The treatment of childhood cases of head lice infestations is a popular news media perennial at the start of the school year, and this Wall Street Journal story falls into that category. It covers the usual elements — prevalence of the infestations among school age children, over-the-counter and prescription treatments, home remedies (which generally don’t work) and reassurance about the pesky but essentially benign health impact.
This story also takes a look at the rise of “lice-combing” salons and newer medications meant to stand in when older medications are ineffective. We were impressed by the depth of the sourcing, along with the details that helped readers assess any potential conflicts of interest among said sources. One thing we wished had been more detailed: How the evidence stacks up for each of the treatments.
As the article itself makes clear, head lice infestation is a widespread, unpleasant, and disruptive — albeit relatively benign — condition that costs millions of families money, aggravation and time in efforts to prevent and treat. Adding to the nuisance of ridding scalps, tresses, clothing and home furnishings of the pests, some of the historic over-the-counter medicinal treatments have lost their power owing to drug-resistant mutations in the lice. Newer prescription medicines are effective, but worry an apparently growing number of parents who work hard to avoid what they consider unnecessary chemical exposure.
Thus, parents are certain to be looking for the best and latest information about treatments.
The article does a good job of noting the cost of the combing salons, as well as cost of the medicinal shampoos and other drug treatments, specifically noting also that insurance may not cover the costs.
The article cites data from a recent review article in a medical journal that outlines the effectiveness (or lack thereof) of the medicinal treatments. “The medications have been found to be from 68% to 87% effective after one or two applications. Most don’t require combing,” the story says. We do wish they story explained what “67% effective” means for a typical person, however.
The careful reader will note that the evidence for the effectiveness of the featured combing salons is mostly anecdotal, and it would have greatly strengthened the article to have been more explicit about this, as well as including more solid proof that standard lice medications are not as effective as they used to be.
The article notes that various organizations and experts consider the chemical/medicinal treatments to be highly safe as well as effective.
The story needed to be more explicit about the quality of evidence for each of the treatment options mentioned–combing, going to a delousing salon, over-the-counter treatments, prescription treatments. Only the latter are mentioned in the context of research.
The story references a review article that compares the different approaches, but it provides no details on what kind of evidence the review is based on.
No disease mongering here, and we were glad the story pointed out that there are no adverse physical health effects from lice.
The article does a very good job of noting the conflicts of interest of those quoted.
The story explored alternatives.
Good job on this. It’s clear that businesses that assist with combing are easy to find, and over-the-counter shampoos are even easier.
What appears to be “new” is the explosion of combing salons and newer prescription shampoos, as well as the review article published last week that evaluates them.
This story doesn’t appear to rely on a news release.
Systematic, Criteria-Driven
Puleeeeease... this 'game changer' weight loss drug causes more nausea and vomiting than a placebo. Some game, some change. My friend Gary would spank you for using the eighth word medical reporters should never, ever use. @garyschwitzer @thackerpd
https://www.healthnewsreview.org/toolkit/just-journalists-writing-tips-case-studies/7-words-and-more-you-shouldnt-use-in-medical-news/ https://twitter.com/OttawaCitizen/status/1361426796126830597
A scary @statnews Op-Ed warns that govt attempts to rein in Pharma may cut off access to "life-changing" drugs.
It takes @garyschwitzer to let us know: the author spent 10 years as Pfizer's public-policy chief. https://twitter.com/garyschwitzer/status/1360325022578053123
.@TranspariMED criticizes STAT op-ed for not disclosing pharma funding of author’s institute - similar to criticism we’ve made of STAT op-eds in the past. @transparify @ThinkTankWatch @icer_review https://www.healthnewsreview.org/2021/02/transparency-watchdog-criticizes-stats-non-disclosure-on-pro-pharma-op-ed/
Comments
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like